Internal medicine and menopause;L'interniste et la menopause

Reproduction Humaine et Hormones

Volumn 13, Issue 3, 2000, Pages 203-209

  Godeau, Pierre ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Alzheimer; Breast cancer; Cholelithiasis; Colorectal cancer; Coronary; Hormone Replacement Therapy; Internal medicine; Menopause; Osteoporosis; Thrombosis

Indexed keywords

CONFERENCE PAPER; FRANCE; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; MENOPAUSE; MENSTRUATION;

EID: 0033911355     PISSN: 09943919     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Rozenbaum H. : Pourquoi la ménopause est-elle devenue un problème de santé publique ? Thérapie 1998; 53 : 49-59.
2. HILL K. : The demography of menopause. Maturitas 1996; 23 : 113-127.
3. GREENDALE GA, LEE NP, ARRIOLA ER. : The menopause. Lancet 1999; 353 : 571-580.
4. FANTL JA, CRADOZO L, MCCLISH DK. : Estrogen therapy in the management of urinary incontinence in postmenopausal women : a meta-analysis. Obstet Gynecol 1994; 83 : 12-18.
5. RAZ R, STAMM WE. : A controlled trail of intravaginal estriol in postmenopaual women with recurrent urinary tract infection. N. Engl. J. Med 1993; 329 : 753-760.
6. PEARLSTEIN T, ROSEN K, STONE AB. : Mood disorders and menopause. Endocrinol Metab Clin North Am 1997; 26 : 279-294.
7. BUSH TI, WHITEMAN KM. : Hormone replacement therapy and risk of breast cancer. JAMA 1999; 281 : 2140-2141.
8. CUMMINGS SR, ECKERT SE, KRUEGER KA et al. : The effect of raloxifen on risk of breast cancer in postmenopausal women. Results from the MORE randomized trial. JAMA 1999; 281 : 2189-2197.
9. PEPI Trial : Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in post-menopausal women. JAMA 1995; 273 : 199-208.
10. MANSON JE. : Postmenopausal hormone therapy and atherosclerotic disease. Am Heart J 1994; 128 : 1337-1343.
11. GRODSTEIN F, STAMPFER M. : The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 1995; 38 : 199-210.
12. HULLEY S, GRADY D, BUSH T et al. : Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and estrogen/progestin replacement study (HERS) research group. JAMA 1998; 280 : 605-613.
13. DALY E, VESSEY MP, HAWKINS MH et al. : Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996; 348 : 977-980.
14. GRODSTEIN F, STAMPFER MJ, MANSON JE et al. : Postmenopausal estrogen and progestin use and risk of cardiovascular disease. N Eng Med 1996; 335 : 453-461.
15. ICK H, DERBY LE, MYERS MW, VASILAKIS C, NEWTON KM. : Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal estrogens. Lancet 1996; 348 : 981-984.
16. COLDITZ GA, HANKINSON SE, HUNTER DJ et al. : The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332 : 1589-1593.
17. WECHSLER B., THI HUONG DU LE. : Lupus érythémateux disséminé et ménopause (soumis pour publication).
18. BUYON JP, KALUNIAN KC, SKOVRON ML, PETRI M, LAHITA R, MERILL J et al. : Can women with systemic lupus erythematosus safely use exogenous estrogens? J Clin Rheumatol 1995; 1 : 205-212.
19. MOK CC, LAU CSS, HO CTK, LE KW, MOK MY, WONG RWS. : Safety of hormonal replacement therapy in postmenopausal patients with systemic lupus erythematosus. Scand J Rheumatol 1998; 27 : 342-346.
20. SANCHEZ-GUERRERO J, LIANG MH, KARLSON MW, HUNTER DJ, COLDITZ GA. : Postmenopausal estrogen therapy and the risk of developing systemic lupus erythematosus. Ann Intern Med 1995; 122 : 430-433.
21. NACHTIGALL LE, NACHTIGALL RH, NACHTIGALL RD, BECKMAN EM. : Estrogen replacement therapy. I : a 10-year prospective study in the relationship of osteoporosis. Obstetr Gynecol 1979; 53 : 277-281.
22. LINDSAY R, HART DM, FORREST C, BAIRD C. : Prevention of spinal osteoporosis in oophrectomised women. Lancet 1980; i : 1151-1154.
23. LUFKIN EG, WAHNER HW, O'FALLON WM et al. : Treatment of post-menopausal osteoporosis with transdermal estrogen. Ann Int Med 1992; 117 : 1-9.
24. MICHAELSSON K, BARON JA, FARAHMAND BY et al. : Hormone replacement therapy and risk of hip fracture: population based case-control study. Br Med J 1998; 316: 1858-1863.
25. CAULEY JA, STEELEY DG, ENSRUD K, ETTINGER B, BLACK D, CUMMINGS SR. : Estrogen replacement therapy and fractures in older women. Ann Int Med 1995; 122 : 9-16.
26. SCHNEIDER DL, BARRET-CONNOR EL, MORTON DJ. : Timing of postmenopausal estrogen for optimal bone mineral density. JAMA 1997; 277 : 543-547.
27. Barett-Connor E. : Postmenopausal estrogen therapy and selected (less-often-considered) disease outcomes. Menopause 1999; 6 : 14-20.
28. GRODSTEIN F, NEWCOMB PA, STAMPFER MJ. : Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 1999; 106 : 574-582.
29. KAWAS C, RESNIK S, MORRISON A. et al. : A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology 1997; 48 : 1517-1521.
30. TANG MX, JACOBS D, STERN Y et al. : Effect of estrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996; 348 : 429-432.
31. HASKELL SG, RICHARDSON ED, HORWITZ RI. : The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature. J Clin Epidemiol 1997; 50 : 1249-1264.
32. YAFFE K, SAWAYA G, LIEBERBURG I, GRADY D. : Estrogen therapy in postmenopausal women. Effects on cognitive function and dementia. JAMA 1998; 279 : 688-695.